Table 2 Microbiological characteristics and medical treatment of patients

Susceptibility pattern

 DS

27

29

93.1

 Monoresistance

3

29

10.3

  INH Resistance

1

29

3.4

  RMP Resistance

1

29

3.4

  Streptomycin Resistance

1

29

3.4

 MDR

0

29

0

 XDR

0

29

0

Antimycobacterial treatment

34

38

89.5

 INH

29

32

90.6

 Rifamycin

30

32

93.8

  Rifampicin

30

32

93.8

  Rifabutin

1

32

3.1

  Rifapentin

1

32

3.1

 EMB

27

32

84.4

 PZA

30

32

93.8

 Fluoroquinolone

9

32

28.1

  Levofloxacin

6

32

18.8

  Ciprofloxacin

1

32

3.1

  Moxifloxacin

2

32

6.3

 Aminoglycoside

  Amikacin

4

32

12.5

  Streptomycin

4

32

12.5

 Linezolid

1

32

3.1

 Cycloserin

1

32

3.1

Adjunctive treatment

 Steroids

15

23

65.2